Back to Agenda
SESSION 3: REGULATORY INNOVATION AND CHALLENGES
Session Chair(s)
Trevor M. Jones, CBE
former Director General ABPI, King's College London, United Kingdom
The objective of this session is to share new paradigms in regulatory science and current developments. To facilitate registration of medicinal products & increase efficiency (through collaboration, work-sharing and implementation of global norms and standards).
Speaker(s)
Lembit Rago, DrMed, MD, PHD
Secretary General, Council for International Organizations of Medical Sciences (CIOMS), Switzerland
WHO Perspective
Florence Roizard, PHARMD
Vice President, Regulatory Affairs International, MSD France, France
Industry Perspective
Hajed M.H Hashan
Deputy of General Director, Gulf Health Council, Saudi Arabia
The Saudi Food and Drug Authority: An Evaluation of Registration Procedures & Good Review Practices in Saudi Arabia in Comparison with Australia, Canada & Singapore
Stuart Russel Walker, PHD
Professor and Consultant, Centre for Innovation In Regulatory Science (CIRS), United Kingdom
A Structured Approach to the Benefit-Risk Assessment of Medicines: Key to Improving Decision Making in Drug Development and the Regulatory Review in the Gulf Region
Have an account?